Target intelligence / Profile preview

Replication termination factor 2 (RTF2)

Target
RTF2
Molecular classification
DNA replication regulatory protein, Replisome component, DNA-binding protein, Other
01

Overview

Replication termination factor 2 is a DNA replication regulatory protein and component of the elongating replisome. It facilitates the localization of the Ribonuclease H2 complex to replication forks, supports normal removal of aberrant ribonucleotides, and ensures efficient DNA replication completion. Under conditions of replication stress, RTF2 is proteasomally removed to enable replication restart. RTF2 plays a vital role in triggering ATR-dependent checkpoint signaling and maintaining genome stability. Deficiency or dysregulation of RTF2 leads to replication fork processing defects, abnormal S/G2 transition, and increased risk for genome instability. Beyond its replication roles, RTF2 restricts influenza virus transcription within the nucleus, acting as an interferon-stimulated antiviral factor. Diseases genetically associated with RTF2 include Amyotrophic Lateral Sclerosis 7 and fungal infection (Trichosporonosis), with emerging evidence of its involvement in cancer through DNA damage response and cell cycle regulation.

Other names
C20orf43RTFDC1AD-007CDA05HSPC164HSPC169CDAO5SHUJUN-3replication termination factor 2 domain-containing protein 1UPF0549 protein C20orf43protein RTF2 homologreplication termination factor 2 domain containing 1
02

Mechanism of action

For antiviral activity: restriction of viral nuclear transcription and enhancement of interferon-stimulated gene responses. For replication stress: regulation of proteasome-mediated removal, control of fork restart and signaling through ATR.

03

Biological functions

Regulation of DNA replication fork progressionReplication fork pausing and restartMaintenance of genome stabilityATR pathway activation in response to DNA damageCellular response to replication stressmRNA processing and splicing regulation (in model organisms)
04

Disease associations

Cancer (implicated in genome integrity maintenance and checkpoint control)Amyotrophic lateral sclerosis 7 (gene-association)Infection (restriction of influenza virus at the nuclear stage)Other (Trichosporonosis—gene association)
05

Safety considerations

Potential safety challenges from genome instability if target activity is disrupted (risk of apoptosis, chromosome breakage, and checkpoint bypass)Overaccumulation or deficiency could induce abnormal nuclear structures or cell cycle progression defects

Beyond the preview

Go deeper on Replication termination factor 2 (RTF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Replication termination factor 2 (RTF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call